GB0905231D0 - Compounds and their use - Google Patents

Compounds and their use

Info

Publication number
GB0905231D0
GB0905231D0 GB0905231A GB0905231A GB0905231D0 GB 0905231 D0 GB0905231 D0 GB 0905231D0 GB 0905231 A GB0905231 A GB 0905231A GB 0905231 A GB0905231 A GB 0905231A GB 0905231 D0 GB0905231 D0 GB 0905231D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0905231A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Priority to GB0905231A priority Critical patent/GB0905231D0/en
Publication of GB0905231D0 publication Critical patent/GB0905231D0/en
Priority to EA201170196A priority patent/EA201170196A1/en
Priority to EP09784728A priority patent/EP2326625A1/en
Priority to PCT/GB2009/001774 priority patent/WO2010007382A1/en
Priority to GEAP200912098A priority patent/GEP20125590B/en
Priority to MX2011000460A priority patent/MX2011000460A/en
Priority to CN200980127932.XA priority patent/CN102099339A/en
Priority to KR1020117001319A priority patent/KR20110036044A/en
Priority to US13/054,688 priority patent/US20110124626A1/en
Priority to CA2731196A priority patent/CA2731196A1/en
Priority to AU2009272486A priority patent/AU2009272486A1/en
Priority to PE2011000024A priority patent/PE20110408A1/en
Priority to JP2011517994A priority patent/JP2011528341A/en
Priority to CL2011000043A priority patent/CL2011000043A1/en
Priority to CO11003062A priority patent/CO6341614A2/en
Priority to DO2011000015A priority patent/DOP2011000015A/en
Priority to IL210722A priority patent/IL210722A0/en
Priority to CR20110049A priority patent/CR20110049A/en
Priority to MA33600A priority patent/MA32550B1/en
Priority to EC2011010838A priority patent/ECSP11010838A/en
Ceased legal-status Critical Current

Links

GB0905231A 2008-07-18 2009-03-26 Compounds and their use Ceased GB0905231D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB0905231A GB0905231D0 (en) 2009-03-26 2009-03-26 Compounds and their use
JP2011517994A JP2011528341A (en) 2008-07-18 2009-07-17 Benzazepine derivatives and their use as histamine H3 antagonists
US13/054,688 US20110124626A1 (en) 2008-07-18 2009-07-17 Benzazepine derivatives and their use as histamine h3 antagonists
AU2009272486A AU2009272486A1 (en) 2008-07-18 2009-07-17 Benzazepine derivatives and their use as hstamine H3 antagonists
PCT/GB2009/001774 WO2010007382A1 (en) 2008-07-18 2009-07-17 Benzazepine derivatives and their use as hstamine h3 antagonists
GEAP200912098A GEP20125590B (en) 2008-07-18 2009-07-17 Benzazepine derivatives and usage thereof as histamine h3 antagonists
MX2011000460A MX2011000460A (en) 2008-07-18 2009-07-17 Benzazepine derivatives and their use as hstamine h3 antagonists.
CN200980127932.XA CN102099339A (en) 2008-07-18 2009-07-17 Benzazepine derivatives and their use as histamine H3 antagonists
KR1020117001319A KR20110036044A (en) 2008-07-18 2009-07-17 Benzeazine derivatives and their use as histamine H3 antagonists
EA201170196A EA201170196A1 (en) 2008-07-18 2009-07-17 DERIVATIVES OF BENZEZEPINES AND THEIR APPLICATION AS H3 HISTAMINE ANTAGONISTS
CA2731196A CA2731196A1 (en) 2008-07-18 2009-07-17 Benzazepine derivatives and their use as hstamine h3 antagonists
EP09784728A EP2326625A1 (en) 2008-07-18 2009-07-17 Benzazepine derivatives and their use as hstamine h3 antagonists
PE2011000024A PE20110408A1 (en) 2008-07-18 2009-07-17 BENZAZEPINE DERIVATIVES AND THEIR USES AS ANTAGONISTS OF HISTAMINE H3
CL2011000043A CL2011000043A1 (en) 2008-07-18 2011-01-07 Substituted benzoazepine derived compounds; intermediate compounds; synthesis method; pharmaceutical composition; and use in the treatment or prevention of a central nervous system disorder.
CO11003062A CO6341614A2 (en) 2008-07-18 2011-01-13 DERIVATIVES OF BENZAZEPIN AND ITS USE AS HISTAMINE ANTAGONISTS H3
DO2011000015A DOP2011000015A (en) 2008-07-18 2011-01-14 DERIVATIVES OF BENZAZEPINA AND ITS USES AS H3 HISTAMINE ANTAGONISTS
IL210722A IL210722A0 (en) 2008-07-18 2011-01-18 Benzazepine derivatives, compositions comprising the same and uses thereof
CR20110049A CR20110049A (en) 2008-07-18 2011-01-25 DERIVATIVES OF BENZAZEPIN AND ITS USE AS HISTAMINE ANTAGONISTS H3
MA33600A MA32550B1 (en) 2008-07-18 2011-02-10 BENZAZEPINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF HISTAMINE H3 RECEPTORS
EC2011010838A ECSP11010838A (en) 2008-07-18 2011-02-18 DERIVATIVES OF BENZAZEPINA AND ITS USES AS HISTAMINE ANTAGONISTS H3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0905231A GB0905231D0 (en) 2009-03-26 2009-03-26 Compounds and their use

Publications (1)

Publication Number Publication Date
GB0905231D0 true GB0905231D0 (en) 2009-05-13

Family

ID=40671776

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0905231A Ceased GB0905231D0 (en) 2008-07-18 2009-03-26 Compounds and their use

Country Status (1)

Country Link
GB (1) GB0905231D0 (en)

Similar Documents

Publication Publication Date Title
ZA201303499B (en) Specific diarylhydantoin and diarylthiohydantion compounds
HUE059796T2 (en) Psma-targeting compounds and uses thereof
GB0919432D0 (en) Use
GB0818241D0 (en) Compounds and their use
SI2344449T1 (en) Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
IL208081A0 (en) Amido - thiophene compounds and their use
ZA201007395B (en) Aryl-quinolyl compounds and their use
ZA201303773B (en) Compounds and their use
GB0922505D0 (en) Use
GB0902173D0 (en) Compounds and their use
GB0922510D0 (en) Compound and use
EP2470022A4 (en) Compounds and methods
GB0801319D0 (en) Compounds and their use
GB0905525D0 (en) Compounds and uses
GB0917304D0 (en) Use
GB0905231D0 (en) Compounds and their use
GB0902013D0 (en) Novel compounds and their use
PL387177A1 (en) Enaminocarbonylic compounds and their application
GB0912237D0 (en) Use
GB0919888D0 (en) Use
GB0907963D0 (en) Use
GB0907472D0 (en) Use
GB0919586D0 (en) Use
GB0817897D0 (en) Compounds and their use
GB0813254D0 (en) Compounds and their use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)